The forecast for anxiolytic medicine sales in Germany from 2024 to 2028 shows a stable trend with consistent values of 1 USD PPP per capita annually. This steadiness suggests a plateau in demand or market saturation, assuming no significant deviation from past trends. Since no year-on-year percentage variations are recorded, it indicates no anticipated real growth or decline over this forecast period. The absence of data prior to 2024 prevents insights into prior trends.

Future trends to watch for include:

Potential impact of new anxiolytic treatments entering the market, which could disrupt current forecasts.
Government healthcare policies that might alter funding and accessibility to anxiety treatments.
Cultural or societal shifts impacting mental health perceptions and treatment demand.